Biomarkers such as neurofilament light chain (Nf-L), tau protein, and S100b reflect the extent of brain injury and are associated with secondary neurodegeneration and correlate with worse functional outcomes post stroke (124, 125). This evidence concerns the gene S100B and stroke disorder.